Abraham Mintz, MD
Neurological Surgery · Shelton, CTNPI 1679538334
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (54.8%), other and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 99.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $111,644 and has fallen 99.6% since, to $471 in 2025. Among neurological surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $10,731 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$203K
- Orthofix Medical, Inc.$486
- Corelink, LLC$183
- Cerapedics Inc.$149
- Amgen$125
- Globus Medical$54
What the payments were for
- Royalty or licence$111,64455%
- Travel & lodging$2190%
- Food & beverage$9300%
- Other$91,10345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $202,899 |
| Orthofix Medical, Inc. | 8 | $486 |
| Corelink, LLC | 1 | $183 |
| Cerapedics Inc. | 1 | $149 |
| Amgen | 1 | $125 |
| Globus Medical | 2 | $54 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- nanoLOCK-C$49,871
- nanoLOCK-L$41,232
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$447
- Mariner$219
- MazorX - Renaissance$151
- EVENITY$125
- Spinal-Stim$119
How this compares
$203,896 in reported general payments places this provider in the 95th percentile of 94 neurological surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 11 | $293 |
| Methylprednisolone | 12 | $90 |
| Cyclobenzaprine Hcl | 23 | $87 |
| Oxycodone Hcl | 12 | $51 |
| Tramadol Hcl | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Shelton
- Judith GorelickShelton$8K
- Murat GunelNew Haven$839K
- Sanjay RathiNorth Haven$541K
- Patrick SenatusSouth Windsor$309K
- Ahmed KhanNew Britain$250K
- Joshua MarcusDanbury$142K
- Pooia FattahiMiddlebury$140K
- Pedro de Oliveira CoutinhoNew Haven$129K
- Ehud MendelNew Haven$120K
- Charles MatoukNew Haven$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.